Table 5.

Multivariate analysis using generalized linear models in patients with frailty score ≥5 (n=119)

QoL Measures and PredictorsAdjusted P Value
SF-12 PCS
 Age0.63
 Sex0.56
 Time on dialysis0.92
 Stoke–Davies comorbidity score0.96
 Frailty score0.68
 HD versus PD0.54
SF-12 MCS
 Age0.89
 Sex0.68
 Time on dialysis0.89
 Stoke–Davies comorbidity score0.86
 Frailty score0.31
 HD versus PD0.67
IIRS
 Age0.43
 Sex0.63
 Time on dialysis0.54
 Stoke–Davies comorbidity score0.86
 Frailty score0.43
 HD versus PD0.56
HADS Score
 Age0.92
 Sex0.63
 Time on dialysis0.96
 Stoke–Davies comorbidity score0.98
 Frailty score0.19
 HD versus PD0.92
Barthel Score
 Age0.96
 Sex0.97
 Time on dialysis>0.99
 Stoke–Davies comorbidity score0.45
 Frailty scorea0.03
 HD versus PD0.96
RTSQ
 Age0.86
 Sex0.85
 Time on dialysis0.32
 Stoke–Davies comorbidity score0.89
 Frailty score0.96
 HD versus PD0.10
Symptoms
 Age0.60
 Sex0.92
 Time on dialysis0.85
 Stoke–Davies comorbidity score0.89
 Frailty score0.10
 HD versus PD0.56
  • QoL, quality of life; SF-12, Short Form-12; PCS, Physical Component Summary; HD, hemodialysis; PD, peritoneal dialysis; MCS, Mental Component Summary; IIRS, Illness Intrusiveness Rating Scale; HADS, Hospital Anxiety and Depression Scale; RTSQ, Renal Treatment Satisfaction Questionnaire.

  • a Significant predictor (P<0.05).